Helen O’Neill on Clubhouse

Bio

Lecturer in Reproductive and Molecular Genetics working on CRISPR genome editing at University College London, UK.

CEO and Founder of Hertility Health @hertility_health

Current Director for the MSc in Reproductive Science and Women's Health at University College London.

Hertility Health is an innovative biotech company on a mission to give women the ability to track their fertility and reproductive health. Research is the focus of our initiative through a machine-learning driven healthcare solution which integrates both a symptom checker and biomarker testing, delivered to the door.
We tailor each woman's individual hormone panel by taking into account her reproductive and medical history. We, therefore, ensure that testing, route-to-diagnosis and care is accurate, accessible and affordable.
We are excited to be the first to offer a 360-degree view into each individual woman’s health and will build on this exponentially to have an inclusive, comprehensive dataset of female pathologies, genetics and biomarkers, enabling ever-learning algorithms to aid remote research and innovation for diagnostics and care.
We are using deep learning to identify women’s increased risk of fertility deterioration and to prompt clinicians to consider more intensive monitoring and interventions.

With at-home blood test, paired with bespoke testing, actionable advice and a route-to-care, we help women learn more about their own biology and plan accordingly. We are tackling the gender data gap through personalised medicine in reproductive health.

www.hertilityhealth.com